Market Place
Sourcing Support
All News #Library
Biotech
OBI Pharma Reveals Ten Poster at AACR 2026 Annual Meeting Posters
15 Apr 2026 //
PHARMIWEB
OBI Pharma Begins Phase 1/2 Study for OBI-902 in Advanced Tumors
02 Sep 2025 //
GLOBENEWSWIRE
OBI Pharma`s OBI-902 Phase 1/2 Study IND Cleared by FDA
30 Apr 2025 //
GLOBENEWSWIRE
OBI Pharma presents ADC posters at AACR 2025 Annual Meeting
22 Apr 2025 //
GLOBENEWSWIRE
Amaran Biotech Signs MOU with Nippon Fine Chemical
06 Mar 2025 //
GLOBENEWSWIRE
OBI Pharma Announces Ph 1/2 Study Initiation for OBI-992, a TROP2-Targeted ADC
12 Jun 2024 //
GLOBENEWSWIRE
OBI Pharma Announces Poster Presentations at the AACR 2024 Annual Meeting
18 Mar 2024 //
GLOBENEWSWIRE
OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 of OBI-992
08 Jan 2024 //
PR NEWSWIRE
OBI Pharma Announces Clearance of IND for a Phase 1/2 Study of OBI-992
03 Jan 2024 //
GLOBENEWSWIRE
OBI Pharma Announces Poster Presentations at AACR 2023 Meeting for OBI-999
10 Apr 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.